Since its establishment in 2022, Ewing Pharma Private Limited has built a strong presence in the pharmaceutical sector through its commitment to manufacturing high-quality APIs, advanced intermediates, and finished dosage forms.

Our core strength lies in the long-standing relationships across the pharmaceutical industry. This trust-driven network has enabled us to retain the trust of our clients and stakeholders.

Our manufacturing capabilities for APIs and advanced intermediates are spread operates over 40,000 sq. ft. of manufacturing facility and multiple loan-licensed facilities, allowing us to scale efficiently from lab-scale development to commercial bulk production for global markets.

We in Ewing Pharma believe that the strength behind every successful organization rests in it’s people. We opt on creating a harmonious environment for every individual and strive to maximize the operational freedom of every employee. The cultural harmony in organization had given every individual a common identity to work towards the ultimate goal of success.

Being the service rendering company we are committed towards this Society offering optimal health benefits to all. We are willing to deliver the highest ethical standards in pharmaceutical practices making the healthcare sector economical and affordable for consumers around the world. On our path of success, we want this world to look over to us as an organization that conducts the business with utmost ethics recognizing the social responsibilities as well.